Montmanguar safeguards eyes in diabetes
An American study found that the medication Tirzepatide, used for treating diabetes and weight loss, reduces the risk of eye complications associated with diabetes, especially retinopathy. The rates of incidence and progression decreased by up to 30-40% compared to those who followed only lifestyle changes. The results also showed that this drug helps reduce the need for specialized treatments such as laser therapy and intraocular injections. However, the study indicates that long-term research is needed to confirm the enduring benefits.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)